COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S - share repurchase programme
06/05/2024
Bagsværd, Denmark, 06 May 2024 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2024 of DKK 20 billion continues. As part of this, Novo Nordisk A/S has now initiated a new share repurchase [...]
Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme
06/05/2024
Bagsværd, Denmark, 06 May 2024 – Today, Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of DKK 0.10 at a value of DKK 5,427,801,225.00 million from Novo Holdings A/S. The transaction is [...]
NMDP’s Amy Ronneberg Recognized as Most Admired CEO by Minneapolis/St. Paul Business Journal
06/05/2024
MINNEAPOLIS, May 06, 2024 (GLOBE NEWSWIRE) -- NMDP SM , a global nonprofit leader in cell therapy, announced today that the Minneapolis / St. Paul Business Journal named CEO Amy Ronneberg to its 2024 list of Most [...]
Bondholders approve amended terms of the 2024 convertible bonds
06/05/2024
Ad hoc announcement pursuant to Art. 53 LR Bondholders approve amended terms of the 2024 convertible bonds The proposed amendments to the terms of the 2024 convertible bond have been approved by the bondholders and will [...]
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024
06/05/2024
Finalizing full data analysis from vafidemstat's PORTICO Phase IIb trial in Borderline Personality Disorder (BPD) Company planning to request an End-of-Phase II meeting with the FDA to discuss plans for a registrational [...]
Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
06/05/2024
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
06/05/2024
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD
06/05/2024
` Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD Leuven, BELGIUM – May 6, 2024 – 6:00 PM CET , Oxurion NV (Euronext Brussels: OXUR), an innovative biopharmaceutical company based [...]
Nicox’s Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024
06/05/2024
Press Release Nicox’s Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 Shareholders adopted all resolutions proposed by the Board of Directors at the Ordinary and Extraordinary General Meetings May 6, [...]
Nicox : assemblée générale ordinaire et extraordinaire du 6 mai 2024
06/05/2024
Communiqué de presse Nicox : assemblée générale ordinaire et extraordinaire du 6 mai 2024 Les actionnaires ont adopté toutes les résolutions à titre ordinaire et à titre extraordinaire agréées par le Conseil d’ [...]
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
06/05/2024
Phase 2 ORCA-V1 trial showed treatment with cytisinicline more than doubled odds of quitting e-cigarettes compared with placebo Cytisinicline treatment well tolerated with no serious adverse events reported and [...]
IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024
06/05/2024
LAWRENCEVILLE, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- IMUNON , Inc. (NASDAQ: IMNN) , a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and next-generation vaccines, announces [...]
Transactions in Connection with Share Buy-back Program
06/05/2024
Company Announcement COPENHAGEN, Denmark; May 6, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares. The [...]
Survey: Nurses See Little Improvement in 2024
06/05/2024
Over One-Third Extremely Likely to Change Jobs DALLAS, May 06, 2024 (GLOBE NEWSWIRE) -- The majority of nurses (80%) think 2024 will be either no better or worse for nurses than 2023, according to a new survey by AMN [...]
Safety Shot Provides Shareholder Update Highlighting Significant Milestones and Progress
06/05/2024
JUPITER, FL, May 06, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (The “Company” or “Safety Shot”) today released a shareholder update to highlight the Company’s progress and strategic vision to maximize [...]
Stride Autism Centers Opens New Facility in Oak Park to Improve Autism Services in Illinois
06/05/2024
OAK PARK, Ill., May 06, 2024 (GLOBE NEWSWIRE) -- Stride Autism Centers ("Stride"), renowned for its mission-driven, evidence-based therapy for children with autism, announces the opening of its innovative new center in [...]
Inmagene Reports Positive Interim Results from Phase 2a Trial of IMG-007, a Nondepleting Anti-OX40 Monoclonal Antibody with an Extended Half-life, for the Treatment of Atopic Dermatitis
06/05/2024
Treatment with IMG-007, the only clinical-stage nondepleting anti-OX40 monoclonal antibody (mAb), led to rapid, marked, and durable improvement of skin signs in patients with atopic dermatitis (AD). Overall, IMG-007 was [...]
Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13
06/05/2024
Company to Host Conference Call, May 13, 2024 at 4:30 p.m. ET SAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based [...]
Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®)
06/05/2024
-- The Centers for Medicare & Medicaid Services (CMS) released its preliminary Medicare payment determinations for the PoNS Controller and Mouthpiece -- -- Public Meeting Scheduled for May 29, 2024 -- NEWTOWN, Pa., [...]

Pages